Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme

		Phase:		Phase 2

		Treatment ID#:		1722

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Not Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed

		Last Updated:		05/29/2006

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Immunological, Biological or Targeted Therapy

		Contact:		Camilo Fadul MD Director Neuro-Oncology Program Dartmouth-Hitchcock Medical Center One Medical Center Drive Lebanon, NH 03756 USA Phone: 603-650-6312 Fax: (603)650-8287 E-mail: camilo.e.fadul@dartmouth.edu Website: www.dartmouth.edu/dms/nccc/brain.htm

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By